New study aims to improve pain relief after cancer surgery
NCT ID NCT06232577
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two different methods for prescribing opioid painkillers to people recovering from abdominal cancer surgery. The goal is to find which approach provides better pain control with fewer side effects. About 170 adults having certain types of abdominal surgery at MD Anderson Cancer Center will take part.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- opioid painkillers (hydrocodone, tramadol, oxycodone)
- What this could lead to
- If successful, this could lead to better pain management guidelines for cancer surgery patients, reducing both pain and opioid-related side effects.
- What could go wrong
- This is a small, early-phase trial (170 participants) comparing prescription models, not testing a new drug. Results may not apply to all surgeries or patients, and pain control varies individually.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRA-ABDOMINAL CANCER are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.